Mohamed S. Abou Donia received his B.Sc. in Pharmacy from the Faculty of Pharmacy, Suez Canal University, Egypt in 2004, and his Ph.D. from the Medicinal Chemistry Department, School of Pharmacy, University of Utah in 2010. After completing his post-doctoral studies at the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco, Mohamed started his independent laboratory in 2014 at the Department of Molecular Biology, Princeton University. There, using a combination of metagenomic, biochemical, and computational approaches, his group investigates the role of the human microbiome in health, disease, and response to therapeutic interventions. Mohamed is a recipient of the NIH Director's New Innovator and Transformative Research Awards, the Kenneth Rainin Foundation Innovation and Breakthrough Awards, the Pershing Square Sohn Prize for Young Investigators in Cancer Research, the Vilcek Prize for Creative Promise in Biomedical Science, and is named a Pew Biomedical Scholar.